Kistler-Tiffany Companies’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $15.8M | Hold |
41,234
| – | – | 2.56% | 6 |
|
|
2023
Q1 | $14.3M | Hold |
41,234
| – | – | 2.72% | 6 |
|
|
2022
Q4 | $9.7M | Hold |
41,234
| – | – | 2% | 8 |
|
|
2022
Q3 | $10.1M | Sell |
41,234
-662
| -2% | -$202K | 2.31% | 7 |
|
|
2022
Q2 | $12.7M | Hold |
41,896
| – | – | 2.76% | 5 |
|
|
2022
Q1 | $17.2M | Hold |
41,896
| – | – | 3.25% | 5 |
|
|
2021
Q4 | $19.6M | Hold |
41,896
| – | – | 3.84% | 3 |
|
|
2021
Q3 | $17.8M | Sell |
41,896
-554
| -1% | -$234K | 4.03% | 2 |
|
|
2021
Q2 | $15.2M | Hold |
42,450
| – | – | 3.51% | 3 |
|
|
2021
Q1 | $12M | Hold |
42,450
| – | – | 3.09% | 6 |
|
|
2020
Q4 | $12M | Sell |
42,450
-6,968
| -14% | -$1.96M | 3.43% | 5 |
|
|
2020
Q3 | $13.6M | Hold |
49,418
| – | – | 4.34% | 3 |
|
|
2020
Q2 | $11.2M | Hold |
49,418
| – | – | 3.98% | 3 |
|
|
2020
Q1 | $7.43M | Hold |
49,418
| – | – | 2.63% | 8 |
|
|
2019
Q4 | $7.43M | Hold |
49,418
| – | – | 2.6% | 8 |
|
|
2019
Q3 | $7.01M | Buy |
49,418
+24,388
| +97% | +$3.36M | 2.66% | 8 |
|
|
2019
Q2 | $3.13M | Sell |
25,030
-24,388
| -49% | -$2.88M | 1.19% | 15 |
|
|
2019
Q1 | $5.45M | Hold |
49,418
| – | – | 2.25% | 9 |
|
|
2018
Q4 | $4.84M | Sell |
49,418
-3,000
| -6% | -$326K | 2.25% | 9 |
|
|
2018
Q3 | $6.47M | Hold |
52,418
| – | – | 2.67% | 8 |
|
|
2018
Q2 | $5.21M | Hold |
52,418
| – | – | 2.31% | 9 |
|
|
2018
Q1 | $4.63M | Sell |
52,418
-1,298
| -2% | -$121K | 1.91% | 10 |
|
|
2017
Q4 | $5.3M | Sell |
53,716
-11,240
| -17% | -$1.1M | 2.09% | 11 |
|
|
2017
Q3 | $6.25M | Sell |
64,956
-7,752
| -11% | -$701K | 2.61% | 7 |
|
|
2017
Q2 | $6.87M | Sell |
72,708
-16
| -0% | -$1.47K | 3.15% | 6 |
|
|
2017
Q1 | $5.93M | Hold |
72,724
| – | – | 2.8% | 6 |
|
|
2016
Q4 | $6.17M | Hold |
72,724
| – | – | 3.02% | 7 |
|
|
2016
Q3 | $5.42M | Hold |
72,724
| – | – | 2.67% | 8 |
|
|
2016
Q2 | $5.52M | Hold |
72,724
| – | – | 2.83% | 8 |
|
|
2016
Q1 | $5.04M | Hold |
72,724
| – | – | 2.81% | 6 |
|
|
2015
Q4 | $4.38M | Sell |
72,724
-34,000
| -32% | -$2.05M | 2.41% | 7 |
|
|
2015
Q3 | $5.78M | Hold |
106,724
| – | – | 3.46% | 5 |
|
|
2015
Q2 | $6.2M | Hold |
106,724
| – | – | 3.72% | 4 |
|
|
2015
Q1 | $6.43M | Hold |
106,724
| – | – | 4.09% | 3 |
|
|
2014
Q4 | $5.68M | Hold |
106,724
| – | – | 3.72% | 4 |
|
|
2014
Q3 | $4.78M | Hold |
106,724
| – | – | 3.19% | 5 |
|
|
2014
Q2 | $4.5M | Hold |
106,724
| – | – | 3.27% | 5 |
|
|
2014
Q1 | $4.7M | Hold |
106,724
| – | – | 3.51% | 5 |
|
|
2013
Q4 | $5.24M | Hold |
106,724
| – | – | 3.93% | 5 |
|
|
2013
Q3 | $4.39M | Hold |
106,724
| – | – | 3.54% | 5 |
|
|
2013
Q2 | $3.75M | Buy |
+106,724
| New | +$3.51M | 3.21% | 5 |
|
Other funds holding WST
DCP
Kistler-Tiffany Companies's WST Position: Q2 2023 in Review
Kistler-Tiffany Companies held its West Pharmaceutical (WST) position steady in Q2 2023 at 41,234 shares worth $15.8M. The position accounts for 2.56% of the portfolio, ranked #6.
Kistler-Tiffany Companies first reported a position in WST in Q2 2013 and has held it in 41 quarters since. The position peaked at $19.6M in Q4 2021. 735 funds tracked by Wall St. Rank hold WST as of Q2 2023.
- Kistler-Tiffany Companies held 41,234 shares of West Pharmaceutical worth $15.8M as of Q2 2023.
- Kistler-Tiffany Companies left its West Pharmaceutical share count unchanged in Q2 2023.
- West Pharmaceutical made up 2.56% of Kistler-Tiffany Companies's portfolio in Q2 2023, its #6 holding.
- Kistler-Tiffany Companies first reported a position in West Pharmaceutical in Q2 2013 and has held it in 41 quarters since.
- Kistler-Tiffany Companies's West Pharmaceutical position peaked at $19.6M in Q4 2021.
- 735 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2023.
Based on Kistler-Tiffany Companies's 13F filing for Q2 2023, filed 1 Aug 2023.